Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Praluent Market Report 2025

Praluent Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Indication (Primary Hypercholesterolemia, Mixed Dyslipidemia, Established Atherosclerotic Cardiovascular Disease (ASCVD)), By Distribution Channel (Hospitals And Clinics, Retail Pharmacies, Specialty Pharmacies), By End-User (Ambulatory Care, Home Care)

Praluent Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Praluent Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Praluent Market Definition

Praluent is a monoclonal antibody used to treat high cholesterol levels, specifically low-density lipoprotein (LDL) cholesterol, known as bad cholesterol. It is used for treating adults with primary hypercholesterolemia or mixed dyslipidemia and reducing cardiovascular risk in patients with established heart disease.

The main indications for praluent are primary hypercholesterolemia, mixed dyslipidemia, and established atherosclerotic cardiovascular disease (ASCVD). Primary hypercholesterolemia is a genetic condition marked by elevated levels of LDL cholesterol in the blood. Praluent, which contains alirocumab, treats this condition by blocking the PCSK9 protein, thereby reducing LDL cholesterol levels. It is distributed through various channels such as hospitals and clinics, retail pharmacies, and specialty pharmacies and is utilized by end users including ambulatory care and homecare.

Praluent Market Segmentation

The praluent market covered in this report is segmented –

1) By Indication: Primary Hypercholesterolemia; Mixed Dyslipidemia; Established Atherosclerotic Cardiovascular Disease (ASCVD)

2) By Distribution Channel: Hospitals And Clinics; Retail Pharmacies; Specialty Pharmacies

3) By End-User: Ambulatory Care; Home Care

Praluent Market Size and growth rate 2025 to 2029: Graph

Praluent Market Size 2025 And Growth Rate

The praluent market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to growing aging population, increasing spending on cholesterol management medications, increasing healthcare awareness, growing need for advanced hypercholesterolemia treatments, escalating prevalence of hypercholesterolemia and cardiovascular diseases worldwide.

Praluent Market Growth Forecast

The praluent market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to the increasing prevalence of cardiovascular diseases, growing awareness of hyperlipidemia management, rising demand for effective cholesterol-lowering treatments, expanding use of PCSK9 inhibitors, increasing adoption of personalized medicine, and rising healthcare investments. Major trends in the forecast period include the development of higher-dose formulations, advancements in drug delivery devices, integration with digital health technologies for remote monitoring, advancements in biotechnology, and the adoption of personalized medicine.

Book your 30 minutes free consultation with our research experts

Contact Us

Praluent Market Driver: Increasing Cardiovascular Disease Drive Market Growth

The rise in prevalence of cardiovascular diseases is expected to propel the growth of the praluent market going forward. Cardiovascular diseases refer to a group of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, heart attacks, and strokes. The rising prevalence of cardiovascular diseases is primarily due to growing rates of unhealthy lifestyles, including poor diet, physical inactivity, and increased tobacco and alcohol use. Praluent helps manage cardiovascular diseases by lowering LDL cholesterol through PCSK9 inhibition, reducing the risk of heart attacks and strokes. For instance, in December 2022, according to the Office for National Statistics, a UK-based government department, 3.6 million people had a cardiovascular condition (6.4%), 3.7 million had a respiratory disease (6.8%), and 6.6 million people (12.1%) had one of these conditions in March 2021. Therefore, the rise in the prevalence of cardiovascular diseases drives the growth of the praluent market.

Praluent Market Driver: Rising Obesity Rates Drive Growth In The Market

The rise in obesity is expected to propel the growth of the praluent market going forward. Obesity refers to a medical condition characterized by excessive body fat accumulation that poses a risk to health, typically defined by a Body Mass Index (BMI) of 30 or higher. The rising prevalence of obesity is largely attributed to shifts in global food systems and eating habits, characterized by increased consumption of ultra-processed foods, sedentary lifestyles, and economic factors that make unhealthy food choices more readily available. Praluent helps obesity by reducing LDL cholesterol levels in individuals with obesity-related dyslipidemia, as it is a PCSK9 inhibitor that enhances the liver's ability to remove LDL cholesterol from the blood, thereby improving cardiovascular health and reducing obesity-related complications. For instance, in 2024, according to a report published by the Office for Health Improvement and Disparities, a UK-based government department responsible for maintaining public health policies, between 2022 and 2023, about 64.0% of adults aged 18 and above in England were considered overweight or obese, a slight increase from the 63.8% recorded in 2021 to 2022. Therefore, the rise in obesity will drive the growth of the praluent market forward.

Global Praluent Market Major Players

Major companies operating in the praluent market are Sanofi S.A.; Regeneron Pharmaceuticals Inc.

Global Praluent Market Trend: Advancements In Personalized Medicine Driving Innovation In Cholesterol Management

The key trend in the praluent market is focusing on developing innovative solutions, such as low-density lipoprotein cholesterol (LDL-C) lowering therapies, to streamline and enhance the effectiveness and precision of patient care. Low-density lipoprotein cholesterol (LDL-C) lowering therapies refer to medical treatments designed to reduce levels of LDL cholesterol, commonly known as ‘bad cholesterol,’ in the blood to decrease the risk of cardiovascular diseases, such as heart attacks and strokes. For instance, in March 2024, Regeneron Pharmaceuticals Inc., a US-based biotechnology company, received the U.S. Food and Drug Administration (FDA) extended approval of praluent (alirocumab) injection to treat children with a genetic form of high cholesterol. This approval has been extended to include its use as an add-on to diet and other LDL-C-lowering therapies for pediatric patients aged 8 and older with heterozygous familial hypercholesterolemia (HeFH). This approach specifically addresses the needs of children and reduces cardiovascular risks in young patients.

Regional Analysis For The Global Praluent Market

North America was the largest region in the praluent market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the praluent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the praluent market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Praluent Market?

The praluent market consists of sales of praluent (alirocumab) injection and one per-filled pen. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Praluent Industry?

The praluent market research report is one of a series of new reports from The Business Research Company that provides praluent market statistics, including the praluent industry's global market size, regional shares, competitors with a praluent market share, detailed praluent market segments, market trends and opportunities, and any further data you may need to thrive in the praluent industry. This praluent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

    Table Of Contents

    1. Executive Summary

    2. Praluent Market Characteristics

    3. Praluent Market Biologic Drug Characteristics

    3.1. Molecule Type

    3.2. Route Of Administration (ROA)

    3.3. Mechanism Of Action (MOA)

    3.4. Safety And Efficacy

    4. Praluent Market Trends And Strategies

    5. Praluent Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    6. Global Praluent Growth Analysis And Strategic Analysis Framework

    6.1. Global Praluent PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    6.2. Analysis Of End Use Industries

    6.3. Global Praluent Market Growth Rate Analysis

    6.4. Global Praluent Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

    6.5. Global Praluent Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

    6.6. Global Praluent Total Addressable Market (TAM)

    7. Global Praluent Pricing Analysis & Forecasts

    8. Praluent Market Segmentation

    8.1. Global Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Primary Hypercholesterolemia

    Mixed Dyslipidemia

    Established Atherosclerotic Cardiovascular Disease (ASCVD)

    8.2. Global Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Hospitals And Clinics

    Retail Pharmacies

    Specialty Pharmacies

    8.3. Global Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Ambulatory Care

    Home Care

    9. Global Praluent Epidemiology Of Clinical Indications

    9.1. Drug Side Effects

    9.2. Incidence And Prevalence of Clinical Indications

    10. Praluent Market Regional And Country Analysis

    10.1. Global Praluent Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    10.2. Global Praluent Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11. Asia-Pacific Praluent Market

    11.1. Asia-Pacific Praluent Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    11.2. Asia-Pacific Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.3. Asia-Pacific Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.4. Asia-Pacific Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    12. China Praluent Market

    12.1. China Praluent Market Overview

    12.2. China Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.3. China Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.4. China Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    13. India Praluent Market

    13.1. India Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.2. India Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.3. India Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14. Japan Praluent Market

    14.1. Japan Praluent Market Overview

    14.2. Japan Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.3. Japan Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.4. Japan Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15. Australia Praluent Market

    15.1. Australia Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.2. Australia Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.3. Australia Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16. South Korea Praluent Market

    16.1. South Korea Praluent Market Overview

    16.2. South Korea Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.3. South Korea Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.4. South Korea Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17. Western Europe Praluent Market

    17.1. Western Europe Praluent Market Overview

    17.2. Western Europe Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.3. Western Europe Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.4. Western Europe Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18. UK Praluent Market

    18.1. UK Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.2. UK Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.3. UK Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19. Germany Praluent Market

    19.1. Germany Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.2. Germany Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.3. Germany Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20. France Praluent Market

    20.1. France Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.2. France Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.3. France Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21. Eastern Europe Praluent Market

    21.1. Eastern Europe Praluent Market Overview

    21.2. Eastern Europe Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.3. Eastern Europe Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.4. Eastern Europe Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22. North America Praluent Market

    22.1. North America Praluent Market Overview

    22.2. North America Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.3. North America Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.4. North America Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23. USA Praluent Market

    23.1. USA Praluent Market Overview

    23.2. USA Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.3. USA Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.4. USA Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24. Canada Praluent Market

    24.1. Canada Praluent Market Overview

    24.2. Canada Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.3. Canada Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.4. Canada Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25. South America Praluent Market

    25.1. South America Praluent Market Overview

    25.2. South America Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.3. South America Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.4. South America Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26. Middle East Praluent Market

    26.1. Middle East Praluent Market Overview

    26.2. Middle East Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.3. Middle East Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.4. Middle East Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27. Africa Praluent Market

    27.1. Africa Praluent Market Overview

    27.2. Africa Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.3. Africa Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.4. Africa Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    28. Praluent Market Competitive Landscape And Company Profiles

    28.1. Praluent Market Competitive Landscape

    28.2. Praluent Market Company Profiles

    28.2.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

    28.2.2. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

    29. Global Praluent Market Pipeline Analysis

    29.1. High Level Clinic Trail Information

    30. Global Praluent Market Competitive Benchmarking And Dashboard

    31. Key Mergers And Acquisitions In The Praluent Market

    32. Recent Developments In The Praluent Market

    33. Praluent Market High Potential Countries, Segments and Strategies

    33.1 Praluent Market In 2029 - Countries Offering Most New Opportunities

    33.2 Praluent Market In 2029 - Segments Offering Most New Opportunities

    33.3 Praluent Market In 2029 - Growth Strategies

    33.3.1 Market Trend Based Strategies

    33.3.2 Competitor Strategies

    34. Appendix

    34.1. Abbreviations

    34.2. Currencies

    34.3. Historic And Forecast Inflation Rates

    34.4. Research Inquiries

    34.5. The Business Research Company

    34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global Praluent Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global Praluent Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Asia-Pacific, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: China, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: India, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: Japan, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Australia, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: South Korea, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: Western Europe, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: UK, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: Germany, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: France, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: Eastern Europe, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: North America, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: USA, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: Canada, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: South America, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: Middle East, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Africa, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: Sanofi S.A. Financial Performance
  • Table 60: Regeneron Pharmaceuticals Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global Praluent Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global Praluent Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Asia-Pacific, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: China, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: India, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: Japan, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Australia, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: South Korea, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: Western Europe, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: UK, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: Germany, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: France, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: Eastern Europe, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: North America, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: USA, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: Canada, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: South America, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: Middle East, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Africa, Praluent Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, Praluent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, Praluent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: Sanofi S.A. Financial Performance
  • Figure 60: Regeneron Pharmaceuticals Inc. Financial Performance

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

Global Cancer Immunotherapy Market Overview And Prospects – Includes Cancer Immunotherapy Market Share

Read More

How Will The Biosimilar Interleukins Market Grow In 2022?

Read More

Latest Cancer Clinical Decision Tools Market Growth Study 2022-2026 By The Business Research Company

Read More

Global Parenteral Nutrition Market Size, Forecasts, And Opportunities – Includes Parenteral Nutrition Market Share

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the biosimilars market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the high potency apis market research report 2022 with industry size, share, segments and market growth

Read More

Graphic Card Global Market Report 2025 – By Type (Dedicated, Integrated, Hybrid), By Device (Computer, Tablet, Smartphone, Gaming Console, Television, Other Devices), By Application (Gaming, Content Creation And Multimedia Reality, Virtual Reality (VR) And Augmented Reality (AR), AI And ML), By Industry (Electronics, IT And Telecommunication, Defense And Intelligence, Media And Entertainment, Other Industries) – Market Size, Trends, And Global Forecast 2025-2034

View Report

French Fries Global Market Report 2025 – By Product (Fresh, Frozen), By Distribution Channel (Supermarkets and Hypermarkets, Convenience Stores, Online, Distributors, Direct Purchase), By End-Use (Food Service, Retail) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Sinus Dilation Devices Global Market Report 2025 – By Product (Balloon Sinus Dilation Devices, Endoscopes, Functional Endoscopic Sinus Surgery (FESS) Instruments Set, Sinus Stents or Implants, Other Products), By Procedure (Standalone, Hybrid), By Application (Adult, Pediatric), By End User (Hospitals, ENT Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Wood Bio-Products Global Market Report 2025 – By Product Type (Biofuels, Bioplastics, Biochemicals, Biocomposites, Pulp And Papers), By Distribution Channel (Offline, Online), By Application (Energy, Packaging, Construction, Automotive, Chemicals), By End Use Industry (Residential, Commercial, Industrial, Infrastructure, Other End Use Industries) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Edge AI Software Global Market Report 2025 – By Component (Solution, Software Tools, Platform, Services, Training And Consulting Services, System Integration Testing, Support And Maintenance), By Data Type (Video And Image Data, Audio Data, Text And Language Data, Environmental And Location Data, Biometric Data, Multi-Modal Data), By Application (Access Control, Autonomous Vehicles, Energy Management, Predictive Maintenance, Remote Monitoring, Telemetry, Video Surveillance, Other Applications), By Vertical (Banking, Financial Services, And Insurance, Government And Public Sector, Healthcare And Life Sciences, Telecommunications, Energy And Utilities, Manufacturing, Automotive, Transportations, And Logistics, Media And Entertainment, Other Verticals) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Central Precocious Puberty Global Market Report 2025 – By Drug (Leuprolide Acetate, Triptorelin, Histrelin Acetate, Nafarelin), By Route Of Administration (Parenteral, Subcutaneous, Intramuscular, Other Routes Of Administrations), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By End-Users (Hospitals, Specialty Clinics, Homecare, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Parenting Apps Global Market Report 2025 – By Type (Pregnancy Tracker Apps, Baby Tracker Apps, Co-parenting Apps, Baby Care Apps), By App Features (Nutrition Advice, Sleep Management, Developmental Milestones, Health Consult), By Distribution Channel (App Stores, Direct Download), By Application (Android System, IOS (iPhone Operating System) System) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Praluent market?

Praluent is a monoclonal antibody used to treat high cholesterol levels, specifically low-density lipoprotein (LDL) cholesterol, known as bad cholesterol. It is used for treating adults with primary hypercholesterolemia or mixed dyslipidemia and reducing cardiovascular risk in patients with established heart disease. For further insights on the Praluent market, request a sample here

How will the Praluent market drivers and restraints affect the market dynamics? What forces will shape the Praluent industry going forward?

The Praluent market major growth driver - Increasing Cardiovascular Disease Drive Market Growth. For further insights on the Praluent market, request a sample here

What is the forecast market size or the forecast market value of the Praluent market?

The Praluent market size has grown strongly in recent years. The praluent market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to growing aging population, increasing spending on cholesterol management medications, increasing healthcare awareness, growing need for advanced hypercholesterolemia treatments, escalating prevalence of hypercholesterolemia and cardiovascular diseases worldwide. The praluent market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to the increasing prevalence of cardiovascular diseases, growing awareness of hyperlipidemia management, rising demand for effective cholesterol-lowering treatments, expanding use of PCSK9 inhibitors, increasing adoption of personalized medicine, and rising healthcare investments. Major trends in the forecast period include the development of higher-dose formulations, advancements in drug delivery devices, integration with digital health technologies for remote monitoring, advancements in biotechnology, and the adoption of personalized medicine. For further insights on the Praluent market, request a sample here

How is the Praluent market segmented?

The praluent market covered in this report is segmented –
1) By Indication: Primary Hypercholesterolemia; Mixed Dyslipidemia; Established Atherosclerotic Cardiovascular Disease (ASCVD)
2) By Distribution Channel: Hospitals And Clinics; Retail Pharmacies; Specialty Pharmacies
3) By End-User: Ambulatory Care; Home Care For further insights on the Praluent market, request a sample here

Which region has the largest share of the Praluent market? What are the other regions covered in the report?

North America was the largest region in the praluent market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the praluent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Praluent market, request a sample here.

Who are the major players in the Praluent market?

Major companies operating in the praluent market are Sanofi S.A.; Regeneron Pharmaceuticals Inc. . For further insights on the Praluent market, request a sample here.

What are the key trends in the Praluent market?

Major trends in the Praluent market include Advancements In Personalized Medicine Driving Innovation In Cholesterol Management. For further insights on the Praluent market, request a sample here.

What are the major opportunities in the Praluent market? What are the strategies for the Praluent market?

For detailed insights on the major opportunities and strategies in the Praluent market, request a sample here.

How does the Praluent market relate to the overall economy and other similar markets?

For detailed insights on Praluent's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Praluent industry?

For detailed insights on the mergers and acquisitions in the Praluent industry, request a sample here.

What are the key dynamics influencing the Praluent market growth? SWOT analysis of the Praluent market.

For detailed insights on the key dynamics influencing the Praluent market growth and SWOT analysis of the Praluent industry, request a sample here.